National Cancer Centre, Singapore — CureCurrent

How to interpret these research links

Connected source records

The exact organization name National Cancer Centre, Singapore appears in 43 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials43

Recruiting shown8

Roles2

SourceClinicalTrials.gov

Clinical trials

43 shown

Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in SingaporeNCT07116161 · lead sponsor · 2025-07-14

Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research ProposalNCT06977360 · lead sponsor · 2025-05-23

Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.NCT06766058 · lead sponsor · 2024-10-22

Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative CareNCT06244953 · lead sponsor · 2024-08-14

A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLCNCT06418412 · lead sponsor · 2024-03-15

Breast Cancer Exercise Intervention StudyNCT05957068 · lead sponsor · 2023-07-01

SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)NCT05724264 · lead sponsor · 2022-07-21

Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer PatientsNCT04340024 · lead sponsor · 2015-09-30

Acceptability and Feasibility of PSC Model of Serious Illness CommunicationNCT07428655 · lead sponsor · 2025-08-25

ACTIVE_NOT_RECRUITING

A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLCNCT05773092 · lead sponsor · 2023-08-01

ACTIVE_NOT_RECRUITING

Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With LetrozoleNCT05286437 · lead sponsor · 2023-02-15

ACTIVE_NOT_RECRUITING

ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in SingaporeNCT05211882 · lead sponsor · 2022-02-14

PSMA-PET Imaging of Salivary Gland Tumours and Other Rare CancersNCT05581979 · lead sponsor · 2022-01-26

Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging BiomarkersNCT04946968 · lead sponsor · 2021-08-24

ACTIVE_NOT_RECRUITING

Impact of a Breast cAncer Survivorship Interprofessional Community Care ModelNCT04660188 · lead sponsor · 2021-03-01

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376NCT04961632 · lead sponsor · 2020-12-23

The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBCNCT04664829 · lead sponsor · 2020-10-01

Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical OutcomesNCT04961489 · lead sponsor · 2020-08-01

Phase 2 Study of Dacomitinib in NSCLCNCT04027647 · lead sponsor · 2019-09-11

ACTIVE_NOT_RECRUITING

Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLCNCT04087473 · lead sponsor · 2019-08-23

Molecular Profiling ProjectNCT04025515 · lead sponsor · 2019-01-11

Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLCNCT03711422 · lead sponsor · 2018-11-16

Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung CancerNCT03091491 · lead sponsor · 2017-04-07

Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer PatientsNCT03429972 · lead sponsor · 2016-09-01

Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast CancerNCT07166367 · lead sponsor · 2016-08-11

Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung CancerNCT02801734 · lead sponsor · 2016-08-01

Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc TherapyNCT02408497 · lead sponsor · 2015-04-01

PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker DiscoveryNCT02804776 · lead sponsor · 2015-01-27

Stereotactic Body Radiotherapy for Organ Confined Prostate CancerNCT02313298 · lead sponsor · 2013-06-01

A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFRNCT01570296 · lead sponsor · 2011-10-03

Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast CancerNCT01394315 · lead sponsor · 2011-08-01

Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic AnalysesNCT01540110 · lead sponsor · 2010-08-11

Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by SurgeryNCT00801411 · lead sponsor · 2008-10-01

Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung CancerNCT00870532 · lead sponsor · 2008-06-01

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast CancerNCT00687648 · lead sponsor · 2008-05-01

Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung CancerNCT00702182 · lead sponsor · 2008-04-01

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by SurgeryNCT00589238 · lead sponsor · 2008-01-01

Head and Neck cancERs International cOviD-19 collabOraTionNCT04632173 · collaborator · 2021-05-03

A Pilot Tele-rehabilitation Trial for Breast Cancer SurvivorsNCT04269967 · collaborator · 2020-11-01

Health-related Quality of Life-intervention in Survivors of Breast and Other Cancers Experiencing Cancer-related Fatigue Using Traditional Chinese Medicine: The HERBAL TrialNCT04104113 · collaborator · 2019-10-24

Accessible Cancer Care to Enable Support for Survivors ProgrammeNCT04014309 · collaborator · 2019-10-01

Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer SurvivorsNCT02931864 · collaborator · 2016-12-06

Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast CancerNCT01309607 · collaborator · 2011-04-01

Sponsor roles

lead sponsor37

collaborator6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.